Benzinga | Jul 27, 2020 11:49AM EDT

Cleveland Research Downgrades Elanco Animal Health to Underperform, Announces $19 Price Target

Cleveland Research downgrades Elanco Animal Health (NYSE:ELAN) from Neutral to Underperform and announces $19 price target.